Skin keratinocytes represent a primary entry site for herpes simplex virus 1 (HSV-1) in vivo. The cellular proteins nectin-1 and herpesvirus entry mediator (HVEM) act as efficient receptors for both serotypes of HSV and are sufficient for disease development mediated by HSV-2 in mice. How HSV-1 enters skin and whether both nectin-1 and HVEM are involved are not known. We addressed the impact of nectin-1 during entry of HSV-1 into murine epidermis and investigated the putative contribution of HVEM. Using ex vivo infection of murine epidermis, we showed that HSV-1 entered the basal keratinocytes of the epidermis very efficiently. In nectin-1-deficient epidermis, entry was strongly reduced. Almost no entry was observed, however, in nectin-1-deficient keratinocytes grown in culture. This observation correlated with the presence of HVEM on the keratinocyte surface in epidermis and with the lack of HVEM expression in nectin-1-deficient primary keratinocytes. Our results suggest that nectin-1 is the primary receptor in epidermis, while HVEM has a more limited role. For primary murine keratinocytes, on which nectin-1 acts as a single receptor, electron microscopy suggested that HSV-1 can enter both by direct fusion with the plasma membrane and via endocytic vesicles. Thus, we concluded that nectin-1 directs internalization into keratinocytes via alternative pathways. In summary, HSV-1 entry into epidermis was shown to strongly depend on the presence of nectin-1, but the restricted presence of HVEM can potentially replace nectin-1 as a receptor, illustrating the flexibility employed by HSV-1 to efficiently invade tissue in vivo. H erpes simplex viruses (HSV) are ubiquitous human pathogens which can cause a range of diseases, from mild, uncomplicated mucocutaneous lesions to life-threatening infections. HSV-1 is dominantly associated with orofacial infections and encephalitis, whereas HSV-2 more likely causes genital infections. To enter its human host, HSV must come into contact with mucosal surfaces, skin, or the cornea. During initial exposure on mucosa or skin, HSV targets epidermal keratinocytes and establishes a primary infection in the epithelium. Cellular entry of HSV relies on the interaction of several viral glycoproteins with various cell surface receptors (1, 2). The envelope glycoprotein D (gD) is essential for the entry process, and only after gD binding to a receptor is fusion with a cellular membrane induced (3). The major gD receptors mediating entry into mouse and human cells are herpesvirus entry mediator (HVEM) and nectin-1 (4-6). HVEM is a member of the tumor necrosis factor receptor superfamily which can activate either proinflammatory or inhibitory signaling pathways (7), while nectin-1 is an immunoglobulin-like cell adhesion molecule (8). A further gD receptor is 3-O-sulfated heparan sulfate, which may also play a role in HSV-1 entry into various cell types (9, 10).